Sort
25,944 grants matching “neurodegeneration”
Molecular Genetics of Manganese Induced Dopamine Neuron Toxicity
$296,753Richard M Nass · Vanderbilt University · R01 · FY2006 · ES
Neuroimaging Core
$296,666Andrew J Saykin · Indiana University Indianapolis · P30 · FY2014 · AG
Drosophila Model of Parkinson's Disease
$296,625Brigham And Women'S Hospital · R01 · FY2005 · NS
Drosophila Model of Parkinson's Disease
$296,625Brigham And Women'S Hospital · R01 · FY2002 · NS
Drosophila Model of Parkinson's Disease
$296,625Brigham And Women'S Hospital · R01 · FY2004 · NS
COMPLEMENT AND NEUROPROTECTION: ALZHEIMER'S DISEASE
$296,625Mount Sinai School Of Medicine Of Nyu · R01 · FY2001 · AG
COMPLEMENT AND NEUROPROTECTION: ALZHEIMER'S DISEASE
$296,625Mount Sinai School Of Medicine Of Nyu · R01 · FY2002 · AG
Drosophila Model of Parkinson's Disease
$296,625Brigham And Women'S Hospital · R01 · FY2003 · NS
LONG TERM EFFECTS OF DIFFUSE BRAIN TRAUMA
$296,608University Of Pennsylvania · R01 · FY2002 · NS
Regulation of Coenzyme A Levels by Panothenate Kinase
$296,550Suzanne Jackowski · St. Jude Children'S Research Hospital · R01 · FY2007 · GM
Gene Therapy And Neurodegeneration
$296,506Brandon Harvey · National Institute On Drug Abuse · ZIA · FY2017 · DA
Redox-Control of MMP-1 and Senescence
$296,462Juan Andres Melendez · State University Of New York At Albany · R01 · FY2012 · AG
Functions of alpha-Synuclein in Neurotransmitter Release
$296,461Jianhua Xu · Augusta University · R01 · FY2014 · NS
Investigating the mechanisms of a multi-state model of Wnt signaling
$296,331David A Brafman · Arizona State University-Tempe Campus · R01 · FY2020 · GM
Administrative Core
$296,280Matthew D Disney · Scripps Florida · P01 · FY2017 · NS
Validation of r(G4C2)exp-binding small molecules in vivo and c9FTD/ALS biomarker development
$296,280Leonard Petrucelli · Scripps Florida · P01 · FY2017 · NS
Mitigation of nuclear pore dysfunction in c9FTD/ALS pathogenesis
$296,280Jeffrey D Rothstein · Scripps Florida · P01 · FY2017 · NS
SPINOCEREBELLAR ATAXIA TYPE 2 - GENE AND GENE PRODUCT
$296,268Cedars-Sinai Medical Center · R01 · FY2003 · NS
CONTROL OF HIV-1 REPLICATION IN PRIMARY HUMAN ASTROCYTES
$296,250St. Luke'S-Roosevelt Inst For Hlth Scis · R01 · FY2000 · NS
Mechanisms involved in Pexophagy
$296,159Suresh Subramani · University Of California, San Diego · R01 · FY2013 · GM
Neuronal RNA processing defects in ALS4 caused by SETX mutations
$296,159Albert R La Spada · University Of California, San Diego · R01 · FY2012 · GM
Neuronal RNA processing defects in ALS4 caused by SETX mutations
$296,159Albert R La Spada · University Of California, San Diego · R01 · FY2011 · GM
ALPHA-SYNUCLEIN-INDUCED AMYLOIDOSIS
$296,137John Q. Trojanowski · University Of Pennsylvania · P01 · FY2008 · AG
Establishing a molecular system for drug targeting of transcriptional control
$296,123Laurence H Hurley · University Of Arizona · R01 · FY2009 · GM
ROLE OF Nna1 IN RETINAL AND CEREBELLAR NEURODEGENERATION
$296,075Albert R La Spada · University Of Washington · R01 · FY2006 · EY